SGRY - Company ID 0001638833
The table below shows Surgery Partners, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $810.90M | $821.50M | $826.20M | $776.00M | $770.40M | $762.10M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Surgery Partners, Inc. reported annual revenue of $3.31B for fiscal year 2025. That is up 6.2% from $3.11B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $959.89M (FY 2015) to $3.31B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $39.30M |
| $22.40M |
| $36.10M |
| $36.00M |
| $29.20M |
| $40.30M |
| Operating income | $65.80M | $105.70M | $111.70M | $61.90M | $60.90M | $84.80M |
| Income tax | -$1.20M | $5.50M | -$1.10M | $0.00 | $4.50M | $4.90M |
| Net income | -$35.90M | -$22.70M | -$2.50M | -$37.70M | -$31.70M | -$15.50M |
| EPS (diluted) | -$0.28 | -$0.18 | -$0.02 | -$0.30 | -$0.25 | -$0.12 |